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Abstract: This paper presents results of electromagnetic compatibility (EMC) testing of three implantable 
neurostimulators exposed to the magnetic fields emitted from several walk-through and hand-held metal detectors. The 
motivation behind this testing comes from numerous adverse event reports involving active implantable medical devices 
(AIMDs) and security systems that have been received by the Food and Drug Administration (FDA). EMC testing was 
performed using three neurostimulators exposed to the emissions from 12 walk-through metal detectors (WTMDs) and 32 
hand-held metal detectors (HHMDs). Emission measurements were performed on all HHMDs and WTMDs and summary 
data is presented. Results from the EMC testing indicate possible electromagnetic interference (EMI) between one of the 
neurostimulators and one WTMD and indicate that EMI between the three neurostimulators and HHMDs is unlikely. The 
results suggest that worst case situations for EMC testing are hard to predict and testing all major medical device modes 
and setting parameters are necessary to understand and characterize the EMC of AIMDs. 
Keywords: EMC, EMI, metal detectors, implantable neurostimulators. 
INTRODUCTION  
  This paper contains detailed information about the 
emissions from a wide range of metal detector systems and 
electromagnetic compatibility (EMC) test findings with three 
widely used implanted neurostimulators. The purpose of this 
paper is to inform physicians, neurostimulator manufac-
turers, and makers of metal detectors about possible EMC 
issues between implantable neurostimulators and metal 
detectors. It is also hoped that relevant guidance on this issue 
will be provided to neurostimulator patients by their 
physicians. Metal detectors referred to in this paper include 
both walk-through metal detectors (WTMDs) and hand-held 
metal detectors (HHMDs). Metal detectors typically use low 
frequency magnetic fields to detect concealed metal objects. 
A typical HHMD and WTMD can be seen in Figs. (1 and 2), 
respectively. 
 
 
 
 
 
 
 
 
Fig. (1). Drawing of a typical HHMD with dimensions (thickness ~ 
3 cm). 
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Fig. (2). Drawing of a typical WTMD with dimensions. 
 
  This work on medical device EMC continues because of 
the Food and Drug Administration’s (FDA) concern of EMC 
issues between active implantable medical devices (AIMD) 
and security systems [1]. There have been 145 adverse event 
reports from 1987-2005 of AIMD malfunctions while in the 
vicinity of security systems. Figs. (3 and 4) shows the 
number of event reports related to EMI between AIMDs and 
security systems, categorized respectively by the type of 
AIMD and the type of security system. FDA's MAUDE 
(Manufacturer and User Facility Device Experience) data 
base is an important indicator of trends related to AIMD 
malfunctions, but the numbers reported are a clear 
underestimation. The increase in event reports since 2004 
may be related to the increase in deployed security systems 
and the general rise in AIMD use. Previous analysis of these 
reports suggests creditable evidence of potentially significant 64    The Open Biomedical Engineering Journal, 2010, Volume 4  Seidman et al. 
electromagnetic interference (EMI) risks for patients using 
certain types of AIMDs [2]. Eisenberg [3] discusses one type 
of potentially harmful EMC event between a neurostimulator 
and electronic article surveillance (EAS) system. Metal 
detectors and EAS systems both emit RF energy in the form 
of low frequency magnetic fields. 
  Some EMC testing has been performed between 
neurostimulators and WTMDs and has been documented by 
Kainz [4]. However this testing involved a limited number of 
continuous wave (CW) WTMDs and one neurostimulator. 
Several other researchers have reported on EMI to non-
neurostimulator AIMDs from security systems including 
work performed at the FDA on implantable cardiac 
pacemakers [5]. This work concluded that WTMDs with 
pulsed waveforms had the potential to cause EMI with 
implantable cardiac pacemakers. Extensive background 
information on neurostimulator EMC can be found in 
Hrdlicka [6] and Kainz [7]. 
MATERIALS AND METHODOLOGY 
A. Walk-Through Metal Detector Emissions 
  Walk-through metal detector emissions were measured 
and evaluated as described by Kainz et al. [5]. Twelve 
WTMDs from seven different manufacturers were evaluated. 
The waveform of each WTMD was digitally captured on a 
LeCroy Waverunner LT264 oscilloscope by placing a three-
axis magnetic field probe (model 1678.002) from Electric 
Research Management (ERM) within 5 cm of the 
transmitting pylon. The waveforms of the WTMD were 
categorized as either pulsed or continuous wave (CW). 
  After the waveform was captured, a computer controlled 
three-axis scanning system [8] was used to scan seven planes 
(both horizontal and vertical) for each WTMD. Each 
WTMD’s emissions were measured using the same three-
axis magnetic field probe from ERM. The results of the 
measurements were analyzed and the absolute maximum and 
two reasonable maximums were recorded for each WTMD. 
The absolute maximum field strength is the highest peak-to-
peak vector magnitude magnetic field measured. The 
reasonable maximum field strength is the highest peak-to-
peak magnetic field value within an area of the WTMD 
where an AIMD could be present while the patient is 
walking through. The boundary defining this area is more 
than 50 cm but less than 150 cm above the floor and not 
closer than 15 cm from either pylon. Two calculations were 
made using the reasonable maximum values within this area:  
 
 
 
 
 
 
 
 
 
 
Fig. (3). Number of AIMD event reports between 1987 and 2005 linked to EMC issues with security systems, categorized by the type of 
AIMD. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (4). Number of AIMD event reports between 1987 and 2005 linked to EMC issues with security systems, categorized by the type of 
security system. 
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1.  Reasonable Maximum Normal to the Pylon:   
y n H H =
 
2. Reasonable Maximum Vector Magnitude: 
2 2 2
z y x v H H H H + + =
. 
  To find the likely exposure for the neurostimulator the 
two reasonable maximums were averaged over an 800 cm
2 
area in the shape of a square and defined as  Hn and Hv , 
respectively. 800 cm
2 was the maximum loop area we could 
represent with our leads provided by Medtronic. Faraday’s 
Law explains how current in a loop generates magnetic 
fields and why a larger loop size would generate a higher 
magnetic field (and thus more of a chance for EMI). Typical 
neurostimulator loop areas range widely from 10 cm
2 to over 
1000 cm
2 [6]. An underestimation of the actual magnetic 
field produced by the WTMD is obtained by considering 
only one field component ( Hn ) instead of all three ( Hv ). 
An overestimation of the actual magnetic field produced by 
the WTMD is obtained by taking the vector magnitude 
( Hv ). Therefore the actual magnetic field exposure to the 
neurostimulator lies somewhere between the averaged values 
Hn and Hv .  
B. Hand-held Metal Detector Emissions 
  Thirty-two HHMDs were evaluated in a similar manner 
as the WTMD evaluations. The emission waveforms of the 
HHMDs were captured using a smaller version of the ERM 
three-axis magnetic field sensor calibrated for higher 
frequencies (model 1709.1) and the same digital oscilloscope 
as used to capture the WTMD emissions. The same three-
axis scanning system was used to map the magnetic field 
strengths from each HHMD. The emission measurements 
scanning protocol was different due to variation in size and 
geometry of a HHMD versus a WTMD. Five horizontal 
planes were scanned at 1.5, 2.0, 2.5, 3.0, and 5 cm above and 
parallel to the radiating surface of each HHMD. Two vertical 
planes, one aligned with the HHMD handle and one 
perpendicular to the HHMD handle were taken. No 
reasonable maximums were considered for HHMD 
measurements because the radiating surface is likely to be 
much closer to the AIMD than from a WTMD. The absolute 
maximum (i.e. the highest peak to peak vector magnitude 
magnetic field strength) was recorded for each HHMD.  
C. Neurostimulator EMC Testing with Walk-Through 
Metal Detectors 
  It is cumbersome to test possible neurostimulator EMI 
directly in a WTMD due to the large testing volume of each 
WTMD. Therefore a metal detector simulator was designed 
in order to mimic magnetic fields emitted by each WTMD. 
The simulator consists of an arbitrary waveform generator, a 
trans-conductance amplifier, and a coil system. The 
simulator generates uniform magnetic fields in a volume 57 
cm long, 42 cm wide, and 14 cm deep and is shown in Fig. 
(5). Details about the design are published in Misakian et al. 
[9] and simulator performance data are published in Kainz  
et al. [5]. All of the EMC testing performed for the WTMD 
emissions in the present study was performed using the 
simulator system. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (5). Photo of the coil system. Five coil loops are mounted to a 
wooden frame to create a uniform exposure field where the 
neurostimulator could be tested. 
 
  Typical neurostimulator settings were chosen in 
accordance with Hrdlicka [6]. All neurostimulators tested 
had an amplitude of 3.0 Volts, a pulse width of 150 
microseconds, and a pulse repetition rate of 70 Hertz. The 
neurostimulator leads formed a loop size of 800 cm
2. The 
three neurostimulators tested along with their operating 
modes were: 
•  Medtronic Itrel3 (NS1): Quadripolar implantable 
pulse generator designed for spinal cord stimulation. 
Tested in both unipolar (NS1U) and bipolar (NS1B) 
modes of operation. 
•  Medtronic Soletra (NS2): Quadripolar 
neurostimulator designed for deep brain stimulation. 
Tested in both unipolar (NS2U) and bipolar (NS2B) 
modes of operation. 
•  Medtronic Synergy (NS3): Dual channel implantable 
pulse generator designed for spinal cord stimulation. 
Tested in SingleStim (NS3SS) mode of operation. 
DualStim mode allows each channel to have different 
amplitudes. DualStim mode settings were not tested. 
SingleStim and DualStim operate only in bipolar 
mode. 
  The neurostimulator output was monitored using the 
LeCroy Waverunner-2 LT-264 digital oscilloscope.  
  To perform testing in air (without a saline-filled 
phantom) the neurostimulator lead loop was closed using a 
500 ohm resistive load and connected to the oscilloscope 
using a twisted cable to avoid possible pick-up from the 
WTMD emissions. To perform testing in the saline-filled 
phantom the electrical path for the neurostimulator lead loop 
was closed with saline. In the saline-filled phantom the 
neurostimulator output was measured using the Srico Optical 
Voltage Probe and Receiver (Model 400-02M) by placing 66    The Open Biomedical Engineering Journal, 2010, Volume 4  Seidman et al. 
the two electrodes of the Srico probe in the saline bath near 
the tip of the neurostimulator lead. The neurostimulator can 
and lead configuration was placed on a flat plastic fixture 
and tied down with thin non-conducting strings. The plastic 
box used for saline testing (i.e., the saline-filled phantom) 
has dimensions of 42 x 57 x 30 cm and was filled with saline 
solution for a conductivity of 0.266 S/m (0.14% salinity). 
This saline phantom test method is modified from the torso 
simulator method developed by Ruggera [10]. From previous 
testing [5] it is believed that air testing is a conservative 
alternative to testing in saline.  
  To observe possible neurostimulator interference the 
output signal of the neurostimulator was monitored on the 
oscilloscope. The field strength generated by the WTMD 
simulator started at 1 A/m and was raised in 1 A/m steps. 
Each field strength level was held for duration of 10 seconds. 
Interference was classified as a change in pulse shape of the 
neurostimulator output and was digitally captured on the 
oscilloscope, Fig. (6), along with the magnetic field strength. 
This magnetic field strength level at which the device is 
affected is called the “interference threshold.” Interference in 
an actual WTMD is possible if an interference threshold was 
found below Hn . If an interference threshold is between 
Hn and Hv  then it is not clear if the WTMD fields will 
interfere with the neurostimulator. If interference was found 
above  Hv then that actual WTMD would not be able to 
produce such interference. The magnetic fields were 
measured using a Wandel and Goldermann EFA-2 EM Field 
Analyzer.  
D. Neurostimulator EMC Testing with Hand-Held Metal 
Detectors 
  The three sample neurostimulator devices were exposed 
to the magnetic field emissions from 32 sample HHMDs to 
assess the EMC among these devices and the HHMDs. The 
actual HHMDs were used rather than the WTMD simulator 
because the WTMD simulator was not able to produce the 
emissions of all HHMDs. The same setup from the WTMD 
EMC tests was used to support and create a level plane to 
test the neurostimulators. An additional plastic fixture was 
placed over the neurostimulator plane to create a testing 
plane for the exposures. This plane created a 1.5 cm 
separation distance between the HHMD and neurostimulator 
as seen in Fig (7).  
  The active HHMD was then placed in one corner of the 
grid and moved in 3 cm intervals over the entire surface. The 
HHMD was held for a duration of 10 seconds in each 
location. Interference behavior was observed and recorded at 
each point. A quick sweep (1 second stop at each location 
instead of 10 seconds) was also performed with the HHMD 
rotated 90, 180, and 270 degrees, as well as with the tip 
touching the testing plane and the HHMD axis perpendicular 
to the testing surface (see Fig. (8)) to see if different 
orientations of the HHMD might result in interference of the 
neurostimulator. 
 
 
 
 
 
 
 
 
Fig. (8). Typical neurostimulator EMC testing with HHMDs 
occurred with the HHMD horizontal to the testing surface (not 
shown). Another orientation included the tip touching the testing 
plane and the HHMD axis perpendicular to the testing surface is 
shown above. 
 
RESULTS 
A. Metal Detector Emission Data 
  WTMDs were categorized as either pulsed or CW with 
frequencies ranging between 210 Hz and 7400 Hz. The 
emission data for all 12 WTMDs is summarized in Table 1. 
 
 
 
 
 
 
 
 
 
 
Fig. (6). Interference observed on a sample neurostimulator output 
signal. The dashed line represents a reference for the 
neurostimulator output signal with no metal detector emissions 
present. The solid line represents the neurostimulator output signal 
in the presence of emissions from a WTMD. This change in pulse 
area was classified as interference to a neurostimulator device. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (7). Simulator configuration for EMC testing of a sample 
neurostimulator while exposed to HHMD emissions. The HHMD 
Support Grid was placed 1.5 cm above the neurostimulator. Electromagnetic Compatibility Testing of Implantable Neurostimulators  The Open Biomedical Engineering Journal, 2010, Volume 4    67 
For the measurements reported in this paper the difference 
between  Hn and Hv averaged about 11 % with a maximum 
of 22 %. 
  Emission maps from a sample HHMD is shown in Figs. 
(9-11). All except one HHMD emitted CW waveforms with 
frequencies ranging from 10 kHz to 1856 kHz. The pulsed 
waveform that HHMD-M emitted was unique among the 
samples. The maximum field strengths emitted by the other 
HHMDs ranged from 2.1 to 67.3 A/m, with HHMD-M 
emitting significantly higher magnetic field strengths of over 
600A/m. The high magnetic field emissions from HHMD-M 
exceeded the range of the 1709.1 ERM probe at 2.5 cm from 
the surface. The emissions were then measured using an 
1850.002 ERM probe at 2 cm measuring 600 A/m. The 
emission data for all HHMDs is summarized in Table 2. 
 
 
 
 
 
 
 
 
 
 
Fig. (9). HHMD emissions from a horizontal plane (overhead 
view). Axes coordinates in cm. 
 
 
 
 
 
 
 
 
 
Fig. (10). HHMD emissions from a vertical-handle-aligned plane 
(side view). Axes coordinates in cm. 
 
 
 
 
 
 
 
 
 
 
 
Fig. (11). Example of HHMD emissions from a vertical-handle-
normal plane (front view). Axes coordinates in cm. 
Table 1.  Summary of the Emission Measurements for 12 Different WTMDs. Primary Frequency, Waveform, Shortest Fall Time 
for Pulsed WTMD Signals. Max H Field Represents the Absolute Maximum Peak to Peak Vector Magnitude Recorded 
During Emission Measurements 
Manufacturer  Model  Abbreviation  Frequency (Hz)  Waveform  Fall Time (us)  Max H Field (A/m) 
A a  Aa  276  25  163.0 
a Ba  400  11.6  288.6 
b Bb  509  10.4  226.4  B 
c Bc  240  7.3  219.9 
Ca1 
a 
Ca2 
569 21.8  265.0 
Cb1 
C 
b 
Cb2 
210 47  473.6 
D a  Da  210 
pulsed 
43.5 378.1 
a  Ea  3520, 4690, 5640  multiple CW  -  122.6 
b Eb  4535  -  91.9  E 
c Ec  7400  -  69.3 
F a  Fa  269  -  465.2 
G a  Ga  5170 
CW 
- 18.8 68    The Open Biomedical Engineering Journal, 2010, Volume 4  Seidman et al. 
B. Walk-Through Metal Detectors 
  Findings for NS1B during air tests indicated the output of 
the device was affected for exposure levels below  Hn from 
WTMD-Bc2. During saline testing the interference threshold 
for NS1U was below  Hn and for NS1B the interference 
threshold was below  Hv from WTMD-Bc2. In most cases 
the interference behavior of NS1 in saline was similar to the 
behavior in air. Saline was generally the worst case scenario 
Table 2.  Summary of the Emission Measurements for 32 HHMDs. Max H Field Represents the Absolute Maximum Peak to Peak 
Vector Magnitude Recorded During Emission Measurements 
Manufacturer  Model  Frequency (kHz)  Max H Field (A/m) 
Ha 21.9  16.9 
Hb 22.5  16.3 
Hc 21.6  19.1 
Hd 20.7  18.6 
He 21.6  25.4 
H 
Hf 20.8  11.3 
Ab 1850 6.4 
A 
Ac 1800 3.2 
Ed 93.2  12.8 
Ee 16.6  30.7  E 
Ef 47.6  15.3 
Bd 95.3  29.0 
Be 97  11.0  B 
Bf 95  13.9 
Ia 135.5  10.7 
Ib 63.8  18.0  I 
Ic 51.1  9.8 
J Ja  23.6  8.5 
K K  87.6  11.8 
La 112 7.1 
L 
Lb 58.3  15.3 
M Ma  10/0.027
a >  600 
G Ga  13.1  67.3 
N Na  23.5  4.0 
O Oa  42.1  33.7 
Pa 24.2 8.9 
Pb 25.4  46.8  P 
Pc 11.5  32.6 
Qa 266 4.3 
Q 
Qb 266 2.1 
R Ra  18.5  16.7 
S Sa  49.6  11.8 
*Pulsed Waveform, Duration 50 us, Repetition Freq 26.75 Hz. Electromagnetic Compatibility Testing of Implantable Neurostimulators  The Open Biomedical Engineering Journal, 2010, Volume 4    69 
as interference thresholds were lower than testing in air. 
There were also several scenarios where interference could 
be found in saline and not in air. All interference thresholds 
for NS1 from testing in air and saline can be found in Figs. 
(12 and 13), respectively. 
  No interference up to the maximum test level (see Figs. 
(12-13) for maximum test levels) was found testing NS2U, 
NS2B, or NS3 for both pulsed and CW type WTMD signals. 
C. Hand-Held Metal Detectors 
  No EMI behavior was observed for all three 
neurostimulators in all operating modes in both air and saline 
while exposed to any HHMD. However, a superimposed 
signal of HHMD-M was picked up by the neurostimulator 
leads when NS1 was exposed to HHMD-M (see Fig. (14)). It 
is unknown what type of effect the patient could receive, if 
anything, from such an exposure. 
DISCUSSION AND CONCLUSION 
  EMC testing was performed for three sample 
neurostimulators in all operating modes exposed to 12 
WTMDs and 32 HHMDs for both air and saline test methods 
(totaling 470 testing combinations). From the testing results 
using the actual HHMDs it seems that neurostimulator 
interference from a HHMD is unlikely. This can be 
explained because the average magnetic field over the 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (12). Interference thresholds for testing in air of the NS1 (Itrel 3) neurostimulator. Interference is possible in the actual WTMD when 
below the averaged reasonable maximum vector magnitude ( Hv ). The magnetic fields are given as peak-to-peak values in A/m. Missing 
interference symbols for a particular WTMD signal indicates that no interference was observed up to the maximum test level for that WTMD 
signal. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (13). Interference thresholds for testing in saline of the NS1 (Itrel3) neurostimulator. Interference is possible in the actual WTMD when 
below the averaged reasonable maximum vector magnitude ( Hv ). The magnetic fields are given as peak-to-peak values in A/m. Missing 
interference symbols for a particular WTMD signal indicates that no interference was observed up to the maximum test level for that WTMD 
signal. 70    The Open Biomedical Engineering Journal, 2010, Volume 4  Seidman et al. 
neurostimulator loop area is much less from HHMDs than 
from WTMDs. 
 
 
 
 
 
 
 
 
 
 
Fig. (14). The top signal is the NS1U output signal when exposed 
to emissions from HHMD-M. The circle shows a superimposed 
signal of HHMD-M that was picked up by the neurostimulator 
leads when NS1 was exposed to HHMD-M. The bottom signal 
shows the NS1U reference output signal with no metal detector 
emissions present.  
 
  Interference was observed for exposures below  Hn in 
two of these combinations with WTMDs. The two 
combinations occurred with the NS1 neurostimulator and 
WTMD-Bc2. The results as a whole do not prove the 
hypothesis [5] that pulsed waveforms are more likely to 
cause interference than CW waveforms. However, the two 
observed cases of interference on the device output did come 
from a pulsed WTMD, and so it seems to provide further 
support for this hypothesis. Discussions with neurostimulator 
manufacturers suggest that they are aware of possible 
reactions to security system emissions and newer generation 
devices have been re-designed and tested for greater 
immunity. Hrdlicka [6] states that it is possible that 
“walkthrough devices may induce significant voltage in the 
lead system to cause stimulation or occasional shocking.” 
Manufacturers of neurostimulators believe the effect of 
unintentional shocking could be caused by a misbalance of 
positive and negative charges as a consequence of a 
disturbed pulse (personal communication between FDA and 
neurostimulator manufacturer). Manufacturers also suggest 
that interference, such as seen in Fig. (9), can be eliminated 
by turning the neurostimulator off before being exposed to a 
metal detector. However certain patients may not want to 
turn their neurostimulators off because this could lead to a 
sudden return of symptoms. 
  An analysis of the interference levels from NS1 show 
that testing in air is not always the worst case situation as 
was seen for implanted cardiac pacemaker interference [5]. 
The present testing also showed that in some cases unipolar 
lead configuration was not always the worst case situation. 
In terms of EMC and potential EMI for medical devices, 
worst case situations are very difficult to predict. For this 
reason, it is encouraged that medical device testing be 
performed for all major device setting parameters and lead 
configurations. EMC testing should be performed up to, and 
beyond, the emission levels of today’s security systems in 
order to address the potential risks for EMI. The number of 
metal detectors will increase over the next years and AIMDs 
should be able to operate without interference while exposed 
to them. FDA is working with standardization committees 
and industry to develop standardized EMC test methods for 
neurostimulators and other AIMDs. 
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